Post Approval Study of the remed System
Recruiting
99 years or below
All
5 participants needed
1 Location
Brief description of study
This Post Approval Study is a multi-center, prospective, open label, single arm cohort study to evaluate the long-term safety, long-term effectiveness, and survival rate in subjects implanted with the remed System from the remed System Pivotal Trial. Up to 94 subjects will be enrolled at up to 21 sites in the United States (US) and five (5) sites in the European Union (EU).
Only subjects who were implanted and actively being followed as part of the remed System Pivotal Trial are eligible for this trial.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: TBD
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 831584